The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ah! Ananda has totally reverted to his Ananda personality. I guess he was banned under that name because he would often call people a bunch of c's and worse if they dared to suggest that his fanatical ramping was over the top in any way. He was almost as bad as LiarBOoth apart from being polar opposite in viewpoint. If you're reading this, Ananda, why don't you migrate over to ADVFN - there are a real bunch of c's over there who are intent on bashing this stock, e.g. theButler, MDI, Glavey, Lewis Winthorpe et al. Or are you afraid of real opposition?
Two points on today's RNS.i would have liked to see some description of BinSina pharmacy (e.g. its reach and presence) for those of us,like me, not familiar with UAE pharmacies.
secondly,the RNS refers to online availability.are there any cultural or social objections to a product like eroxon being sold in retail outlets in the UAE? BinSina does have retail outlets, so just wondering if there has to be some limitation of sale outlets. not suggesting there is any restriction, just enquiring if anyone familiar with the emirates could comment.
Says cheerfully the xmas grinch :) pls buy my bad then!
You guys are the most miserable bunch of c's I have ever come across.
Moan moan moan
Sell up and move on if you cant handle it
Sad
Everything is a marketing tool. From the staff handbook to the TV advert to the invite to the office Christmas party. Every output tells someone what your company is all about. And in the absence of any other PR or basic marketing from Futura, they really do have to make the most of what they do put out.
Barder's family Christmas cards must be a real hoot.
"It's Christmas. Techniclly another year has passed since we last wrote. We will write again at the next Christmas. Signed, James Barder and immediate family."
... and the crowd goes wild :( , what gives?
Yes, I partly agree Banzai.
RNS is not primarily for marketing, but a notification.
But there is no harm in notifying share holders and future investors that this company thinks it's onto a winner.
Therefore instilling confidence and investment.
Read the RNS again.
"Futura announces Eroxon is available online in UAE"
Just a couple of extra words would of made the RNS pop.
How about " Futura is PLEASED to announced that Eroxon is available online in UAE. This is the first market in the Middle East to stock the product and will be available for X million men.
It piques the interest a bit more.
Good news, I really see this taking off in the UAE
An RNS is not a marketing tool. It's not meant to sizzle or be imaginative.
PR and marketing will sizzle, on other channels, when the regional deployment is in place. This is the first excellent step of that regional deployment.
The fact that there are no numbers means we are spared the endless speculation on how many needs sold to meet the number, what's the likely margin, why is the dreamed up margin different to margin in Europe.... ad-nauseum
Revenues will come on a concise RNS of there own in due course. Keep the faith.
For me... Great RNS!
It is rare to come across a company that appears to be completely devoid of imagination, self-promotion and positivity. JB is extremely dour as a personality and this comes across in communication. My 5-year granddaughter could have written a more exciting RNS than this one. Anyone would think that they don’t want anyone to know about Eroxon. I will say it again, this comes across as amateur and that they are not savvy enough to communicate to the market which is very irritating indeed. The irony is that most companies without much to shout about over-exaggerate, but we do the opposite!! Hire someone smart with a marketing bent who understand the value of effective communication before you miss the boat!!
This is still the Barder effect.
Of course the RNS itself is basically like someone being forced to apologise and doing so in as few words as possible, through gritted teeth while looking anywhere bit at the person they're talking to.
But also, he recently said come back in 2025 for profits so the market knows these new sales won't put us in profit. Why would they buy in?
If this was America there would be a dozen legal firms proposing a class action.
Wish they would stop releasing RNSs , it's destroying the share price.
Neighbouring Saudi Arabia next? Report in August suggested Q4 launch this year for Saudi with full marketing campaign by Labatec. Some estimates that 10% of males there have ED. (20 million male population). UAE male population just shy of 7 million and unusually 68% of population there are male.
In the hope that someone from Futura PR / marketing reads this..
Come on!!
Sell the sizzle, not the sausage!!!
Can’t believe this isn’t moving up….. come on FUM…. Take a bit of you’re own medicine
What a **** RNS! Would have been nice to now the approx revenue expected!
Great RNS and market to be in 👍
Really positive news !
Big profit there. £36 for 4 tubes!! Hope FUM has some of that.
Wow James, don’t dress it up!
One can hypothesize regarding the SP to keep the BB conversation flowing. However, the crux of the matter is for most part the daily traded volumes hardly replicate a flood. The SP on the other hand is being marked down in a deliberate and calculated manner.
As far as the product is concerned, nothing has changed. It has been clinically proved and gained CE and FDA stamp of approval. Sales are going through in limited market and according to released RSNs everything is progressing as expected.
This product is 'stepping on many toes', and it is hardly unexpected that there will be a backlash of sort. We have already seen price cuts and increased commercialization by competitors.
Regarding negative reviews, it's a fact, and has also been highlighted, that this is not going to work for everyone. Add a little bit of mischief and.....
FUM disappointed on two fronts. (Not helping the languishing SP)
1} Lackluster response to marketing at launch. why was this product not featured on the main news and all national newspapers. (Poor PR)
2) Dealt/dealing with the City whilst wearing the 'unambitious' hat. (Poor City links)
There should a requirement for two vacancies to be filled. PR manager and House broker.
Can see this jumping back above 50 pence really quickly on USA update. Good upside potential now. Looks like its turning now and heading up.
Discoman,i think you are correct.if you refer to the RNS of 13th sept 2022, you will see it refers specifically to the covid restrictive regime in china and that this prevented co-high from delivering on its obligations. fum stated they were trying to take steps to remedy the situation, but clearly these failed.not sure if there were any restrictions on riverwood selling during the agreement period,as ire call there were 2 or 3 changes in the holding after the agreement was announced, but i accept that it is very probable that they have been selling since it was formally terminated and the we may simply have to wait for that process to be completed. as an aside,i do not share the opinion of those who have criticised the bod for the failure of the co-high licence.it seems to have been an unfortunate consequence of covid,such as has adversely affected many investments.anyway,regardless of culpability,what seems more important now is the conclusion of a fresh licence for that area and i would reference the statement in the last RNS that there has been significant interest(my words)particularly following the FDA approval.i am therefore, hopeful (and confident) of very positive news here in due course.
The cancellation had nothing to do with trade.As I understand it High Co were to navigate the obtaining of regulatory approval and establishing a market .Selling in China was not anticipated for a number of years.High Co were given very favourable share purchase/loan note/warrant exercise terms.
Depending on when they have sold/selling they will have been very well rewarded for failure!
Tell ya what's cancelled, futura's xmas card. In my portfolio, it is only FUM sporting a red floppy today and so far this month. What gives?
I thought High Co were cancelled because they said they couldn't deliver.
Which at the time I thought this was reasonable, as China was in lockdown and had went on to have the longest lockdown in the world.
During that lockdown there was very strict import/export regulations and also strict movement of people.
Resulting in very little trade being done and hence the contract being cancelled.
This is all from my jaded memory.
DYO
I'll be.pleased to be corrected and learn something new on this.